Deutsche Bank’s CARGO Therapeutics CRGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-34,266
Closed -$141K 3626
2025
Q2
$141K Sell
34,266
-597
-2% -$2.56K ﹤0.01% 3116
2025
Q1
$142K Sell
34,863
-14,424
-29% -$96.6K ﹤0.01% 3098
2024
Q4
$711K Buy
49,287
+10,471
+27% +$190K ﹤0.01% 2434
2024
Q3
$716K Buy
38,816
+11,956
+45% +$214K ﹤0.01% 2278
2024
Q2
$441K Sell
26,860
-2,042
-7% -$38.8K ﹤0.01% 2390
2024
Q1
$645K Buy
28,902
+14,774
+105% +$351K ﹤0.01% 2229
2023
Q4
$327K Buy
+14,128
New +$240K ﹤0.01% 2604

Other funds holding CRGX

Deutsche Bank's CRGX Position: Q3 2025 in Review

Deutsche Bank sold out of CARGO Therapeutics (CRGX) in Q3 2025, closing a stake of 34,266 shares — an estimated $141K sold.

Deutsche Bank first reported a position in CRGX in Q4 2023 and held it in 7 quarters. The position peaked at $716K in Q3 2024. 1 fund tracked by Wall St. Rank holds CRGX as of Q3 2025.

  • Deutsche Bank reported no remaining CARGO Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Deutsche Bank sold 34,266 CARGO Therapeutics shares in Q3 2025, an estimated $141K.
  • Deutsche Bank first reported a position in CARGO Therapeutics in Q4 2023 and held it in 7 quarters.
  • Deutsche Bank's CARGO Therapeutics position peaked at $716K in Q3 2024.
  • 1 fund tracked by Wall St. Rank held CARGO Therapeutics as of Q3 2025.

Based on Deutsche Bank's 13F filing for Q3 2025, filed 13 Nov 2025.